Skip to main content

Advertisement

SpringerLink
Log in

Knockdown of Angiopoietin-2 Suppresses Metastasis in Human Pancreatic Carcinoma by Reduced Matrix Metalloproteinase-2

  • Research
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

Angiopoietin-2 (Ang2) has been shown highly expressed in resected human pancreatic carcinoma samples, and has tightly combination with tumor angiogenesis, but the role in metastasis of it is less clear. We were, therefore, interested in exploring the effects of Ang2 silencing on the invasion and metastasis of pancreatic carcinoma. Lentivirus (LV)-mediated Ang2 small hairpin RNA (LV-RNAi) and mock lentivirus (LV-NC) were transfected into pancreatic carcinoma cell line MIA PaCa-2. Groups were designed in this study: the control group (MIA PaCa-2 cells), the LV-NC group (cells transfected with the LV-NC), the LV-RNAi-KD1 group (cells transfected with LV-RNAi of knock down sequence (1) and the LV-RNAi-KD2 group (cells transfected with LV-RNAi of knock down sequence (2). Boyden chamber transwell assay was used to detect the cell invasion change. The protein levels of Ang2, MMP-2, and MMP-9 gene and mRNA level of MMP-2, MMP-9 were detected by Western blot and real-time polymerase chain reaction, respectively. Orthotopic pancreatic carcinoma xenotransplantation model were successfully built with MIA PaCa-2 cells injection. After treatment with intraperitoneal injection of LV-RNAi-KD2 (LV-RNAi), mice growth, liver function test, tumor volume and peritoneal metastatic numbers were observed and counted. Moreover, expression of Ang2, MMP-2, MMP-9 were measured by immunohistochemistry. Ang2 expression were successfully knocked down in two LV-RNAi groups, especially in the LV-RNAi-KD2group. Compared with the control group and the LV-NC group, the mRNA and protein level of MMP-2 gene were downregulated significantly in LV-RNAi groups, also the invasion cell number decreased in boyden chamber transwell assay after LV-RNAi transfection. Meanwhile, no obvious MMP-9 gene expression changes were found among all the groups. LV-RNAi injection inhibited pancreatic carcinoma metastasis and growth in vivo by downregulating the expression of MMP-2 not MMP-9. Most importantly, LV-mediated gene therapy with Ang2 knockdown exhibited almost no toxicity in vivo. These findings demonstrate that Ang2 gene silencing exert an anti-metastasis effect in vitro and in vivo, and Ang2 targeted gene therapy has the potential to serve as a novel way for pancreatic carcinoma treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

Ang2:

Angiopoietin-2

LV:

Lentivirus

RNAi:

RNA interference

GFP:

Green fluorescent protein

LV-NC:

The mock lentivirus

MOI:

Multiplicity of infection

References

  1. Hidalgo, M. (2010). Pancreatic cancer. New England Journal of Medicine, 362(17), 1605–1617.

    Article  CAS  Google Scholar 

  2. Duan, X., Deng, L., Chen, X., Lu, Y., Zhang, Q., Zhang, K., et al. (2011). Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer. Medical Oncology, 28(2), 466–474.

    Article  CAS  Google Scholar 

  3. Yao, J., & Qian, C. (2010). Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway. Medical Oncology, 27(3), 1017–1022.

    Article  CAS  Google Scholar 

  4. Ghadially, R. (2011). The role of stem and circulating cells in cancer metastasis. Journal of Surgical Oncology, 103(6), 555–557. doi:10.1002/jso.21807.

    Article  Google Scholar 

  5. Chaffer, C. L., & Weinberg, R. A. (2011). A perspective on cancer cell metastasis. Science, 331(6024), 1559–1564.

    Article  CAS  Google Scholar 

  6. Hu, B., & Cheng, S. Y. (2009). Angiopoietin-2: Development of inhibitors for cancer therapy. Current Oncology Reports, 11(2), 111–116.

    Article  CAS  Google Scholar 

  7. Lewis, C. E., De Palma, M., & Naldini, L. (2007). Tie2-expressing monocytes and tumor angiogenesis: Regulation by hypoxia and angiopoietin-2. Cancer Research, 67(18), 8429–8432.

    Article  CAS  Google Scholar 

  8. Zhou, J., Zhang, Z. X., Zhao, H., Zhu, D. M., Zhang, Y., & Li, D. C. (2011). Anti-angiogenesis by lentivirus-mediated small interfering RNA silencing of angiopoietin-2 gene in pancreatic carcinoma. Technology in Cancer Research and Treatment, 10(4), 361–369.

    CAS  Google Scholar 

  9. Lares, M. R., Rossi, J. J., & Ouellet, D. L. (2010). RNAi and small interfering RNAs in human disease therapeutic applications. Trends in Biotechnology, 28(11), 570–579.

    Article  CAS  Google Scholar 

  10. Nijwening, J. H., & Beijersbergen, R. L. (2010). Using large-scale RNAi screens to identify novel drug targets for cancer. IDrugs, 13(11), 772–777.

    CAS  Google Scholar 

  11. Haugk, B. (2010). Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer? Histopathology, 57(4), 503–514. doi:10.1111/j.1365-2559.2010.03610.x.PMID:20875068.

    Article  Google Scholar 

  12. Ryozawa, S., Iwano, H., Taba, K., Sen-yo, M., & Uekitani, T. (2011). Genetic diagnosis of pancreatic cancer using specimens obtained by EUS-FNA. Digestive Endoscopy, 23(Suppl 1), 43–45. doi:10.1111/j.1443-1661.2011.01117.x.

    Article  Google Scholar 

  13. Plentz, R. R., Manns, M. P., & Greten, T. F. (2010). Molecular therapy of pancreatic cancer. Minerva Endocrinologica, 35(1), 27–33.

    CAS  Google Scholar 

  14. Shapiro, R., Strydom, D. J., Olson, K. A., & Vallee, B. L. (1987). Isolation of angiogenin from normal human plasma. Biochemistry, 26(16), 5141–5146.

    Article  CAS  Google Scholar 

  15. Fukuhara, S., Sako, K., Noda, K., Zhang, J., Minami, M., & Mochizuki, N. (2010). Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histology and Histopathology, 25(3), 387–396.

    CAS  Google Scholar 

  16. Eklund, L., & Olsen, B. R. (2006). Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Experimental Cell Research, 312(5), 630–641.

    Article  CAS  Google Scholar 

  17. Imanishi, Y., Hu, B., Xiao, G., Yao, X., & Cheng, S. Y. (2011). Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway. Journal of Biological Chemistry, 286(33), 29249–29260.

    Article  CAS  Google Scholar 

  18. Sallinen, H., Heikura, T., Laidinen, S., Kosma, V. M., Heinonen, S., Ylä-Herttuala, S., et al. (2010). Preoperative angiopoietin-2 serum levels: A marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer. International Journal of Gynecological Cancer, 20(9), 1498–1505.

    Google Scholar 

  19. Volkova, E., Willis, J. A., Wells, J. E., Robinson, B. A., Dachs, G. U., & Currie, M. J. (2011). Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer. British Journal of Cancer, 104(1), 51–59.

    Article  CAS  Google Scholar 

  20. Imanishi, Y., Hu, B., Jarzynka, M. J., Guo, P., Elishaev, E., Bar-Joseph, I., et al. (2007). Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway. Cancer Research, 67(9), 4254–4263.

    Article  CAS  Google Scholar 

  21. Hashizume, H., Falcon, B. L., Kuroda, T., Baluk, P., Coxon, A., Yu, D. Y., et al. (2010). Complementary, actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth. Cancer Research, 70(6), 2213–2223. doi:10.1158/0008-5472.

    Article  CAS  Google Scholar 

  22. Doyle, J. L., & Haas, T. L. (2009). Differential role of beta-catenin in VEGF and histamine-induced MMP-2 production in microvascular endothelial cells. Journal of Cellular Biochemistry, 107(2), 272–283.

    Article  CAS  Google Scholar 

  23. Liotta, L. A., & Kohn, E. C. (2001). The microenvironment of the tumour-host interface. Nature, 411(6835), 375–379.

    Article  CAS  Google Scholar 

  24. He, Y., Liu, X. D., Chen, Z. Y., Zhu, J., Xiong, Y., Li, K., et al. (2007). Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR–uPA–MMP-2 cascade in pancreatic cancer metastasis. Clinical Cancer Research, 13(11), 3115–3124.

    Article  CAS  Google Scholar 

  25. Kenny, H. A., & Lengyel, E. (2009). MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle, 8(5), 683–688.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, The First Affiliated Hospital of Soochow University, 188 Shizi Road, Suzhou, 215006, China

    Zi-Xiang Zhang, Jin Zhou, Yi Zhang, Dong-Ming Zhu, De-Chun Li & Hua Zhao

Authors
  1. Zi-Xiang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jin Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dong-Ming Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. De-Chun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hua Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hua Zhao.

Additional information

Zi-Xiang Zhang and Jin Zhou have contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, ZX., Zhou, J., Zhang, Y. et al. Knockdown of Angiopoietin-2 Suppresses Metastasis in Human Pancreatic Carcinoma by Reduced Matrix Metalloproteinase-2. Mol Biotechnol 53, 336–344 (2013). https://doi.org/10.1007/s12033-012-9532-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12033-012-9532-9

Keywords

Search

Navigation